Vaginal Acidity Affects Vaginal Microbiota in Postmenopausal Women

Juminten Saimin, Yenti Purnamasari, Sufiah Asri Mulyawati, Nur Indah Purnamasari, Arimaswati Arimaswati, Ferry Sandra

Abstract


BACKGROUND: The changes in vaginal acidity impact the composition of the vaginal microbiota, either commensal or pathogenic. After menopause, the vaginal tract is more susceptible to infection. Current study was conducted to analyze the effect of vaginal acidity changes on the vaginal microbiota composition in menopausal women.

METHODS: A cross-sectional study was conducted on 32 subjects with vulvovaginal atrophy (VVA). Vaginal pH was measured using a strip with colorimetric examination. The detection of Candida sp. was done by using 10% potassium hydroxide. Meanwhile for detection of Trichomonas vaginalis, Gardnerella vaginalis, Lactobacillus iners, and Lactobacillus crispatus, polymerase chain reaction was performed. The data were statistically analyzed.

RESULTS: G. vaginalis was the mostly found pathogenic microorganism in current study (40.63%), followed by Candida sp. (25%). Further analysis showed that G. vaginalis were found in L. crispatus positive samples for 9 cases and L. iners positive samples for 9 cases. Candida sp. had an increased risk at vaginal pH ≥6 (OR=8.273), T. vaginalis had a reduced risk at vaginal pH ≥6 (OR=0.765), G. vaginalis had an increased risk at vaginal pH ≥6 (OR=1.440), L. crispatus had an reduced risk at vaginal pH ≥6 (OR=0.077), while L. crispatus had an increased risk at vaginal pH ≥6 (OR=1.111).

CONCLUSION: Vaginal acidity alterations in postmenopausal women affect either commensal or pathogenic microorganism composition. A decrease in the number of L. crispatus and an increase in the number of L. iners and pathogenic microorganisms is in line with the increase of pH.

KEYWORDS: Lactobacillus, microbiota, menopause, pathogenic microorganisms, vaginal acidity


Full Text:

PDF

References


Ranuh RG, Athiyyah AF, Darma A, Riawan W, Surono IS, Sandra F, et al. Lactobacillus plantarum IS-20506 probiotic restores galectin-4 and myosin-1a expressions in duodenum, jejunum and ileum of lipopolysaccharide-induced rats. Indones Biomed J. 2020; 12(3): 283-7, CrossRef.

Valentina I, Achadiyani, Adi SS, Lesmana R, Farenia R. Effect of Lactobacillus reuteri administration on wrinkle formation and type I procollagen levels in UVB-exposed male Balb/c mice (Mus musculus). Mol Cell Biomed Sci. 2020; 4(3): 113-20, CrossRef.

Amin M, Goodarzi H, Orang Z, Farsi S, Jorfi M. Isolation and identification of lactobacillus species from the vagina and their antimicrobial properties. Afr J Microbiol Res. 2011; 5(20): 3300-4, CrossRef.

Dasari S, Karanam S, Anandan, Rajendra W, Valluru L. Role of microbial flora in female genital tract: A comprehensive review. Asian Pac J Trop Dis. 2016; 6(11): 909-17, CrossRef.

De Backer E, Verhelst R, Verstraelen H, Alqumber MA, Burton JP, Tagg JR, et al. Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners. BMC Microbiol. 2007; 7: 115, CrossRef.

Dumonceaux TJ, Schellenberg J, Goleski V, Hill JE, Jaoko W, Kimani J, et al. Multiplex detection of bacteria associated with normal microbiota and with bacterial vaginosis in vaginal swabs by use of oligonucleotide-coupled fluorescent microspheres. J Clin Microbiol. 2009; 47(12): 4067-77, CrossRef.

Zozaya-Hinchliffe M, Lillis R, Martin DH, Ferris MJ. Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J Clin Microbiol. 2010; 48(5): 1812-9, CrossRef.

Fredricks DN. Molecular methods to describe the spectrum and dynamics of the vaginal microbiota. Anaerobe. 2011; 17(4): 191-5, CrossRef.

Srinivasan S, Hoffman NG, Morgan MT, Matsen FA, Fiedler TL, Hall RW, et al. Bacterial communities in women with bacterial vaginosis: High-resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS One. 2012; 7(6): e37818, CrossRef.

Kusters JG, Reuland EA, Bouter S, Koenig PS, Dorigo-Zetsma JW. A multiplex real-time PCR assay for routine diagnosis of bacterial vaginosis. Eur J Clin Microbiol Infect Dis. 2015; 34: 1779-85, CrossRef.

Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med. 2009; 6: 2133-42, CrossRef.

Immanuel AI, Wantania J, Suparman E, Lintong P. Clinical appearance and vaginal cytology of atrophic vaginitis in postmenopausal women. Indones J Obstet Gynecol. 2010; 34(2): 92-6, article.

Nappi RE, Kokot-Kierepa M. Women’s voices in menopause result from an international survey on vaginal atrophy. Maturitas. 2010; 67(3): 233-8, CrossRef.

Simon JA, Kokot-Kierepa M, Goldstein J, Nappi RE. Vaginal health in the United States, results from the vaginal health, insights, views, and attitudes survey. Menopause. 2013; 20(10): 1043-8, CrossRef.

Minkin MJ, Maamari R, Reiter S. Postmenopausal vaginal atrophy: Evaluation of treatment with local estrogen therapy. Int J Women’s Health. 2014; 6: 281-8, CrossRef.

Saimin J, Hendarto H, Soetjipto. The effect of tomato juice in increasing Ki-67 expression and epithelial thickness on the vaginal wall of menopausal rats. Indones Biomed J. 2019; 11(2): 152-8, CrossRef.

Sturdee DW, Panay N. International Menopause Society Writing Group Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010; 13(6): 509-22, CrossRef.

Amran R. Menentukan menopause berdasarkan indeks maturasi dan pH vagina. JKK. 2010; 42(3): 2981-6, article.

Grady D. Management of menopausal symptoms. N Engl J Med. 2006; 355(22): 2338-47, CrossRef.

Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician. 2000; 61(10): 3090-6, article.

WHO. Sexually Transmitted and Other Reproductive Tract Infections: A Guide to Essential Practice. Geneva: World Health Organization; 2005, article.

Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015; 64(No. RR–3): 1-137, article.

Saimin J, Ridwan S, Purnamasari NI, Irawati, Purnamasari Y, Mulyawati SA. Clinical symptoms of vulvovaginitis among premenopausal women: A retrospective study in Southeast Sulawesi. The International Congress of Asia-Oceania Research Organisation in Genital Infection and Neoplasia (AOGIN). 2021 April 9-11.

Takahashi TA, Johnson KM. Menopause. Med Clin N Am. 2015; 99(3): 521-34, CrossRef.

Matthes ACS, ZuccaMatthes G, Oliveira MA. The genito urinary syndrome of menopause presents sexual symptoms that can be best explained by the relative short vagina syndrome. Gynecol Obstet (Sunnyvale). 2016; 6(1): 382, CrossRef.

Gliniewicz K, Schneider GM, Ridenhour BJ, Williams CJ, Song Y, Farage MA, et al. Comparison of the vaginal microbiomes of premenopausal and postmenopausal women. Front Microbiol. 2019; 10: 193, CrossRef.

Mirmonsef P, Modur S, Burgad D, Gilbert D, Golub ET, French AL, et al. Exploratory comparison of vaginal glycogen and Lactobacillus levels in premenopausal and postmenopausal women. Menopause. 2015; 22(7): 702-9, CrossRef.

Hummelen R, Macklaim JM, Bisanz JE, Hammond JA, McMillan A, Vongsa R, et al. Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness. PLoS One. 2011; 6(11): e26602, CrossRef.

Brotman RM, Shardell MD, Gajer P, Fadrosh D, Chang K, Silver MI, et al. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause. 2014; 21(5): 450-8, CrossRef.

Barrons R, Tassone D. Use of Lactobacillus probiotics for genitourinary infections in women: A review. Clin Ther. 2008; 30(3): 453-68.

Verstraelen H, Verhelst R, Claeys G, De Backer E, Temmerman M, Vaneechoutte M. Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and/or L. iners are more conducive to the occurrence of abnormal vaginal microflora. BMC Microbiol. 2009; 9: 116, CrossRef.

Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011; 52(10): 1212-7, CrossRef.




DOI: https://doi.org/10.18585/inabj.v14i2.1836

Copyright (c) 2022 The Prodia Education and Research Institute

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

Indexed by:

                  

                     

          

 

 

The Prodia Education and Research Institute